These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15178691)

  • 1. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells.
    Wang L; Lin HK; Hu YC; Xie S; Yang L; Chang C
    J Biol Chem; 2004 Jul; 279(31):32444-52. PubMed ID: 15178691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
    Ueda T; Bruchovsky N; Sadar MD
    J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cells.
    Nakata D; Koyama R; Nakayama K; Kitazawa S; Watanabe T; Hara T
    Prostate; 2017 Jun; 77(9):955-961. PubMed ID: 28397338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
    Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
    J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
    Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
    J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor.
    Verras M; Sun Z
    Mol Endocrinol; 2005 Feb; 19(2):391-8. PubMed ID: 15514031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity.
    Salas TR; Kim J; Vakar-Lopez F; Sabichi AL; Troncoso P; Jenster G; Kikuchi A; Chen SY; Shemshedini L; Suraokar M; Logothetis CJ; DiGiovanni J; Lippman SM; Menter DG
    J Biol Chem; 2004 Apr; 279(18):19191-200. PubMed ID: 14985354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.
    Schütz SV; Schrader AJ; Zengerling F; Genze F; Cronauer MV; Schrader M
    PLoS One; 2011; 6(9):e25341. PubMed ID: 21980429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3beta kinase pathways.
    Yang WJ; Chang CJ; Yeh SH; Lin WH; Wang SH; Tsai TF; Chen DS; Chen PJ
    Hepatology; 2009 May; 49(5):1515-24. PubMed ID: 19205031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
    Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
    J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor.
    Sugita S; Kawashima H; Tanaka T; Kurisu T; Sugimura K; Nakatani T
    Oncol Rep; 2004 Jun; 11(6):1273-9. PubMed ID: 15138566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
    Gregory CW; Fei X; Ponguta LA; He B; Bill HM; French FS; Wilson EM
    J Biol Chem; 2004 Feb; 279(8):7119-30. PubMed ID: 14662770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.
    Lee DK; Duan HO; Chang C
    J Biol Chem; 2001 Mar; 276(13):9978-84. PubMed ID: 11266437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.
    Wang Q; Udayakumar TS; Vasaitis TS; Brodie AM; Fondell JD
    J Biol Chem; 2004 Apr; 279(17):17319-28. PubMed ID: 14966121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
    Salas TR; Reddy SA; Clifford JL; Davis RJ; Kikuchi A; Lippman SM; Menter DG
    J Biol Chem; 2003 Oct; 278(42):41338-46. PubMed ID: 12900420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer.
    Campa VM; Baltziskueta E; Bengoa-Vergniory N; Gorroño-Etxebarria I; Wesołowski R; Waxman J; Kypta RM
    Oncotarget; 2014 Sep; 5(18):8173-87. PubMed ID: 25327559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
    Lee LF; Guan J; Qiu Y; Kung HJ
    Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.